Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - COST OF REVENUE
Cost of Revenue RARE - Ultragenyx Pharmaceutical Inc.
45.2 M
LAST VALUE
68.05%
2 YEAR CAGR
108.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR